|
1AST
STRUCTURE OF ASTACIN AND IMPLICATIONS FOR ACTIVATION OF ASTACINS AND ZINC-LIGATION OF COLLAGENASES
提交 1993-04-21
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
50–249(200 aa)
|
未记录
|
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 1.80 Å
|
|
1IAA
CRYSTAL STRUCTURES, SPECTROSCOPIC FEATURES, AND CATALYTIC PROPERTIES OF COBALT(II), COPPER(II), NICKEL(II), AND MERCURY(II) DERIVATIVES OF THE ZINC ENDOPEPTIDASE ASTACIN. A CORRELATION OF STRUCTURE AND PROTEOLYTIC ACTIVITY
提交 1994-05-09
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
50–249(200 aa)
|
未记录
|
CU COPPER (II) ION × 1
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 1.90 Å
|
|
1IAB
CRYSTAL STRUCTURES, SPECTROSCOPIC FEATURES, AND CATALYTIC PROPERTIES OF COBALT(II), COPPER(II), NICKEL(II), AND MERCURY(II) DERIVATIVES OF THE ZINC ENDOPEPTIDASE ASTACIN. A CORRELATION OF STRUCTURE AND PROTEOLYTIC ACTIVITY
提交 1994-05-09
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
50–249(200 aa)
|
未记录
|
CO COBALT (II) ION × 1
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 1.79 Å
|
|
1IAC
REFINED 1.8 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF ASTACIN, A ZINC-ENDOPEPTIDASE FROM THE CRAYFISH ASTACUS ASTACUS L. STRUCTURE DETERMINATION, REFINEMENT, MOLECULAR STRUCTURE AND COMPARISON WITH THERMOLYSIN
提交 1994-05-09
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
50–249(200 aa)
|
未记录
|
HG MERCURY (II) ION × 1
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.10 Å
|
|
1IAD
REFINED 1.8 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF ASTACIN, A ZINC-ENDOPEPTIDASE FROM THE CRAYFISH ASTACUS ASTACUS L. STRUCTURE DETERMINATION, REFINEMENT, MOLECULAR STRUCTURE AND COMPARISON TO THERMOLYSIN
提交 1994-05-09
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
50–249(200 aa)
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.30 Å
|
|
1IAE
CRYSTAL STRUCTURES, SPECTROSCOPIC FEATURES, AND CATALYTIC PROPERTIES OF COBALT(II), COPPER(II), NICKEL(II), AND MERCURY(II) DERIVATIVES OF THE ZINC ENDOPEPTIDASE ASTACIN. A CORRELATION OF STRUCTURE AND PROTEOLYTIC ACTIVITY
提交 1994-05-09
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
50–249(200 aa)
|
未记录
|
NI NICKEL (II) ION × 1
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 1.83 Å
|
|
1QJI
Structure of astacin with a transition-state analogue inhibitor
提交 1999-06-24
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
50–249(200 aa)
片段:CATALYTIC DOMAIN
|
未记录
|
ZN ZINC ION × 1
PKF CARBOBENZOXY-PRO-LYS-PHE-Y(PO2)-ALA-PRO-OME × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7;HANGING DROP VAPOUR DIFFUSION PH 7.0, 1M AMMONIUM SULFATE
|
分辨率 2.14 Å
|
|
1QJJ
Structure of astacin with a hydroxamic acid inhibitor
提交 1999-06-24
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 A
50–249(200 aa)
片段:CATALYTIC DOMAIN
|
未记录
|
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7;HANGING DROP VAPOUR DIFFUSION PH 7.0, 1M AMMONIUM SULFATE
|
分辨率 1.86 Å
|
|
6HT9
Mouse fetuin-B in complex with crayfish astacin
提交 2018-10-03
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 A
1–251(251 aa)
|
未记录
|
ZN ZINC ION × 1
GOL GLYCEROL × 3
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;ammonium sulfate, polyethylene glycol 2000, sodium acetate, pH 4.6.
|
分辨率 3.10 Å
R-free 0.270
|
|
6HT9
Mouse fetuin-B in complex with crayfish astacin
提交 2018-10-03
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 C
1–251(251 aa)
|
未记录
|
ZN ZINC ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;ammonium sulfate, polyethylene glycol 2000, sodium acetate, pH 4.6.
|
分辨率 3.10 Å
R-free 0.270
|
|
6SAZ
Cleaved human fetuin-b in complex with crayfish astacin
提交 2019-07-18
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 A
50–251(202 aa)
|
未记录
|
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;Crystallization assays were set up following the sitting-drop vapor diffusion method at the joint IBMB/IRB Automated Crystallography Platform of Barcelona Science Park. A Tecan robot (Tecan Trading) was used to prepare reservoir solutions, and a Cartesian Microsys 4000 XL robot (Genomic Solutions) or a Phoenix nanodrop robot (Art Robbins Instruments) dispensed nanocrystallization drops on 96x2-well Swissci Polystyrene MRC Crystallization Plates (Molecular Dimensions). Plates were stored at 4 or 20 degrees in thermostatic crystal farms (Bruker AXS). The astacin-hFB complex only crystallized after incubating the inhibitor (at 7.5 mg/mL) with six-fold molar excess of the peptidase in 10 mM Tris-HCl, 140 mM sodium chloride, pH 6.8. Crystals were obtained at 20 degrees in 200 nL:100 nL drops with protein complex solution and 20 percent (w/v) polyethylene glycol 3,350, 0.2 M sodium tartrate dibasic as reservoir solution.
|
分辨率 3.00 Å
R-free 0.247
|
|
6SAZ
Cleaved human fetuin-b in complex with crayfish astacin
提交 2019-07-18
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
其他组合
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 C
50–251(202 aa)
|
未记录
|
ZN ZINC ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;Crystallization assays were set up following the sitting-drop vapor diffusion method at the joint IBMB/IRB Automated Crystallography Platform of Barcelona Science Park. A Tecan robot (Tecan Trading) was used to prepare reservoir solutions, and a Cartesian Microsys 4000 XL robot (Genomic Solutions) or a Phoenix nanodrop robot (Art Robbins Instruments) dispensed nanocrystallization drops on 96x2-well Swissci Polystyrene MRC Crystallization Plates (Molecular Dimensions). Plates were stored at 4 or 20 degrees in thermostatic crystal farms (Bruker AXS). The astacin-hFB complex only crystallized after incubating the inhibitor (at 7.5 mg/mL) with six-fold molar excess of the peptidase in 10 mM Tris-HCl, 140 mM sodium chloride, pH 6.8. Crystals were obtained at 20 degrees in 200 nL:100 nL drops with protein complex solution and 20 percent (w/v) polyethylene glycol 3,350, 0.2 M sodium tartrate dibasic as reservoir solution.
|
分辨率 3.00 Å
R-free 0.247
|